Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT04083235 - Fluorouracil (5-FU) + Leucovorin + Liposomal Irinotecan + Oxaliplatin vs Gemcitabine + Nab-paclitaxel / Protein-bound paclitaxel & Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

An Open-label, Randomised, Multicentre, Phase III Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Leucovorin Versus Nab-paclitaxel Plus Gemcitabine in Subjects Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas

Primary outcome measures:
Overall survival (OS)…

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!

NCT04083235 - Fluorouracil (5-FU) + Leucovorin + Liposomal Irinotecan + Oxaliplatin vs Gemcitabine + Nab-paclitaxel / Protein-bound paclitaxel & Pancreatic Ductal Adenocarcinoma (PDAC) / Pancreatic Cancer

Welcome to meRfi Microbiome!

Navigation

Contents

AI Chat

Links